459 related articles for article (PubMed ID: 28348485)
1.
Hou XF; Xu LP; Song HY; Li S; Wu C; Wang JF
World J Gastroenterol; 2017 Mar; 23(10):1796-1803. PubMed ID: 28348485
[TBL] [Abstract][Full Text] [Related]
2. Expression of bcl-2 and p53 in induction of esophageal cancer cell apoptosis by ECRG2 in combination with cisplatin.
Song HY; Deng XH; Yuan GY; Hou XF; Zhu ZD; Zhou L; Ren MX
Asian Pac J Cancer Prev; 2014; 15(3):1397-401. PubMed ID: 24606472
[TBL] [Abstract][Full Text] [Related]
3. Effect of ECRG2 in combination with cisplatin on the proliferation and apoptosis of EC9706 cells.
Song HY; Deng XH; Hou XF; Yuan GY; Zhu ZD; Ren MX
Exp Ther Med; 2014 Nov; 8(5):1484-1488. PubMed ID: 25289046
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of autophagy regulating chemoresistance in esophageal cancer cells.
Fang F; Li Y; Chang L
Exp Mol Pathol; 2020 Dec; 117():104564. PubMed ID: 33137292
[TBL] [Abstract][Full Text] [Related]
5. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
6. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.
Wang TH; Wan JY; Gong X; Li HZ; Cheng Y
Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effects of esophageal cancer related gene 2 on proliferation of human esophageal cancer cell EC9706].
Li MN; Huang G; Guo LP; Lu SH
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2785-8. PubMed ID: 16324322
[TBL] [Abstract][Full Text] [Related]
8. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
Shen W; Liang B; Yin J; Li X; Cheng J
Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of MACC1 expression enhances cisplatin sensitivity in SKOV-3/DDP cells.
Chen ZM; Shi HR; Li X; Deng YX; Zhang RT
Genet Mol Res; 2015 Dec; 14(4):17134-44. PubMed ID: 26681060
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.
Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z
Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825
[TBL] [Abstract][Full Text] [Related]
11. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
Liu L; Fan J; Ai G; Liu J; Luo N; Li C; Cheng Z
Biol Res; 2019 Jul; 52(1):37. PubMed ID: 31319879
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells.
Yu G; Zhong N; Chen G; Huang B; Wu S
Tumour Biol; 2014 Oct; 35(10):10341-9. PubMed ID: 25038915
[TBL] [Abstract][Full Text] [Related]
13. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.
Shi H; Mao Y; Ju Q; Wu Y; Bai W; Wang P; Zhang Y; Jiang M
Int J Oncol; 2018 Jul; 53(1):167-176. PubMed ID: 29658564
[TBL] [Abstract][Full Text] [Related]
14. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
15. ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis.
Cui Y; Wang J; Zhang X; Lang R; Bi M; Guo L; Lu SH
Biochem Biophys Res Commun; 2003 Mar; 302(4):904-15. PubMed ID: 12646258
[TBL] [Abstract][Full Text] [Related]
16. Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo.
Gu J; Tang Y; Liu Y; Guo H; Wang Y; Cai L; Li Y; Wang B
Cancer Lett; 2014 Feb; 343(2):200-9. PubMed ID: 24161623
[TBL] [Abstract][Full Text] [Related]
17. [Effects of recombinant human interleukin-24 alone and in combination with cisplatin on the growth of ovarian cancer cells in vitro].
Wang S; Guo J; Tang Y; Zheng R; Song M; Sun W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jan; 30(1):33-6. PubMed ID: 24405596
[TBL] [Abstract][Full Text] [Related]
18. [Combination of cytosine arabinoside and cisplatin enhances inhibition of cell proliferation and promotes apoptosis of resistant nasopharyngeal carcinoma cells].
Chen J; Liu S; Li Q; Peng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):379-82, 386. PubMed ID: 25744845
[TBL] [Abstract][Full Text] [Related]
19. Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2.
Xu L; Zhang B; Li W
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576437
[TBL] [Abstract][Full Text] [Related]
20. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]